White or near white crystalline powder
Specific rotation +46°~+50°
Related substances≤1.5%
Loss on drying ≤1.0%
Assay≥99.0%
Nucleoside Anticancer Drug; mainly used for treatment of Acute lymphocytic leukemia,is the first product approved for being dedicated to the treatment of the children's leukemia in more than ten year
Related intermediates:
CAS No.6974-32-9 beta-D-Ribofuranose 1-acetate 2,3,5-tribenzoate
CAS No.22224-41-5 1,3,5-Tri-O-benzoyl-D-ribofuranose
CAS No.97614-43-2 2-Deoxy-2-fluoro-1,3,5-tri-O-benzoyl-D-ribofuranose
CAS No.97614-44-3 2-Deoxy-2-fluoro-alpha-D-arabinofuranosyl bromide 3,5-dibenzoate